
Isomorphic Labsrevenue & acquisition
Biotech & Drug DevelopersLondon, United KingdomFounded 2021
Isomorphic Labs was acquired.
Isomorphic Labs is a new Alphabet company and commercial venture which aims to reimagine the entire drug discovery process from first principles with an AI-first approach.
Isomorphic Labs revenue
Isomorphic Labs has not published its revenue. Growjo puts it at about $45.7M a year (September 2024).
| As of | Revenue | Source |
|---|---|---|
| Sep 2024 | $45.7MEST | Growjo estimate |
Who owns Isomorphic Labs
Another company owns Isomorphic Labs. The date and price of the deal are not on record.
Isomorphic Labs CEO
Eamon Jubbawy was CEO of Isomorphic Labs.
Browse Biotech & Drug Developers
How this page is sourced
1 estimate. Founder figures link to the second they were said; public figures name their source; estimates are marked EST and say whose they are. Not financial advice.
Updated Oct 30, 2026Data disclaimerReport a correctionClaim this profileRun Isomorphic Labs? Join the podcast